↓ Skip to main content

Anticancer Drug Development Guide

Overview of attention for book
Cover of 'Anticancer Drug Development Guide'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 High-Volume Screening
  3. Altmetric Badge
    Chapter 2 High-Throughput Screening in Industry
  4. Altmetric Badge
    Chapter 3 The NCI Human Tumor Cell Line (60-Cell) Screen
  5. Altmetric Badge
    Chapter 4 Human Tumor Screening
  6. Altmetric Badge
    Chapter 5 Murine L1210 and P388 Leukemias
  7. Altmetric Badge
    Chapter 6 In Vivo Methods for Screening and Preclinical Testing
  8. Altmetric Badge
    Chapter 7 Human Tumor Xenograft Models in NCI Drug Development
  9. Altmetric Badge
    Chapter 8 NCI Specialized Procedures in Preclinical Drug Evaluations
  10. Altmetric Badge
    Chapter 9 Patient-Like Orthotopic Metastatic Models of Human Cancer
  11. Altmetric Badge
    Chapter 10 Preclinical Models for Combination Therapy
  12. Altmetric Badge
    Chapter 11 Models for Biomarkers and Minimal Residual Tumor
  13. Altmetric Badge
    Chapter 12 Spontaneously Occurring Tumors in Companion Animals as Models for Drug Development
  14. Altmetric Badge
    Chapter 13 Nonclinical Testing
  15. Altmetric Badge
    Chapter 14 Nonclinical Testing for Oncology Drug Products
  16. Altmetric Badge
    Chapter 15 Nonclinical Testing for Oncology Biologic Products
  17. Altmetric Badge
    Chapter 16 Working With the National Cancer Institute
  18. Altmetric Badge
    Chapter 17 Phase I Trial Design and Methodology for Anticancer Drugs
  19. Altmetric Badge
    Chapter 18 Phase II Trials
  20. Altmetric Badge
    Chapter 19 Drug Development in Europe
  21. Altmetric Badge
    Chapter 20 The Phase III Clinical Cancer Trial
  22. Altmetric Badge
    Chapter 21 Assessing Tumor-Related Symptoms and Health-Related Quality of Life in Cancer Clinical Trials
  23. Altmetric Badge
    Chapter 22 The Role of the Oncology Drug Advisory Committee in the FDA Review Process for Oncologic Products
  24. Altmetric Badge
    Chapter 23 FDA Role in Cancer Drug Development and Requirements for Approval
Attention for Chapter 17: Phase I Trial Design and Methodology for Anticancer Drugs
Altmetric Badge

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Phase I Trial Design and Methodology for Anticancer Drugs
Chapter number 17
Book title
Anticancer Drug Development Guide
Published by
Humana Press, Totowa, NJ, January 2004
DOI 10.1007/978-1-59259-739-0_17
Book ISBNs
978-1-4684-9841-7, 978-1-59259-739-0
Authors

Patrick V. Acevedo, Deborah L. Toppmeyer, Eric H. Rubin, Acevedo, Patrick V., Toppmeyer, Deborah L., Rubin, Eric H.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 50%
Unknown 1 50%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 50%
Unknown 1 50%